BAJAJ BROKING
Yatharth Hospital acquires a 60% stake in MGS Infotech for ₹91.2 crore, securing a 400-bed super-speciality project in Faridabad, Haryana, slated to open in 6–10 months.
Yatharth Hospital and Trauma Care Services Ltd recently announced its acquisition of a 60% equity stake in MGS Infotech Research and Solutions Private Ltd. Valued at ₹91.2 crore, this strategic move positions Yatharth Hospital to broaden its footprint in the healthcare industry across the Delhi-NCR region. The acquisition, reflecting an enterprise value of ₹152 crore, enables Yatharth to harness new opportunities in providing specialised healthcare services.
MGS Infotech, established in 2004, owns a 400-bed hospital project situated in Faridabad, Haryana, strategically located to cater to a significant population base in the Delhi-NCR region. The upcoming hospital spread across 2 acres, is set to be operational within 6 to 10 months of this acquisition. With an authorised share capital of ₹80 crore and a paid-up capital of ₹78.47 crore, MGS Infotech represents a robust addition to Yatharth’s healthcare offerings.
Yatharth Hospital aims to reinforce its presence in the competitive Delhi-NCR healthcare market by securing a majority stake in MGS Infotech. The acquisition aligns with the company’s strategy to provide super-speciality medical services to a wider audience. The hospital will feature state-of-the-art medical equipment, allowing Yatharth to enhance patient care services with advanced technology and expertise. Expanding into Faridabad not only diversifies Yatharth’s service network but also strengthens its brand as a key healthcare provider.
This acquisition, approved by Yatharth Hospital’s board on 30 October 2024, is expected to close by December 2024. Notably, the transaction does not require additional regulatory approvals, enabling a smoother transition and faster operational integration. The anticipated timeline ensures that Yatharth Hospital will begin offering healthcare services in the new Faridabad facility by mid-2025, thus supporting the company’s growth and competitive position.
As Yatharth Hospital incorporates MGS Infotech into its healthcare portfolio, the MGS Infotech share price is likely to reflect investor sentiment surrounding the transaction. The acquisition highlights MGS Infotech’s potential to contribute to Yatharth’s expansion goals, further reinforcing its valuation and growth prospects.
This strategic investment in MGS Infotech marks Yatharth Hospital’s dedication to extending high-quality healthcare across the Delhi-NCR region. With the completion of this acquisition, Yatharth positions itself to serve a larger patient base with enhanced super-speciality services, advancing its mission to provide exceptional healthcare solutions.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading